Divergence of the apoptotic pathways induced by 4-hydroxynonenal and amyloid beta-protein

Neurobiol Aging. 2004 Sep;25(8):1057-66. doi: 10.1016/j.neurobiolaging.2003.10.003.

Abstract

In this paper, we examine the hypothesis that 4-hydroxynonenal (HNE), a product of lipid peroxidation, is a key mediator of cell death resulting from beta-amyloid exposure. We revisit the effects of HNE on different neuronal cell types to determine which caspase or caspases are required for HNE-induced death, and to compare these results with the known caspase requirements in other death paradigms. We have previously shown that in a given neuronal cell type different death stimuli can evoke stimulus-specific apoptotic pathways. We now show that HNE treatment of neuronal cells induced dose-dependent death and caspase activity which were blocked by inhibition of caspases. Antisense down-regulation of caspases-3, -7 or -9 provided complete protection from HNE-induced death, as did down-regulation of the caspase regulators APAF-1 and DIABLO. Conversely, this work and our previous studies of three other death paradigms show that caspase-3 is not required for death induced by beta-amyloid, SOD1 down-regulation, or trophic factor deprivation. We also show that HNE accumulated in settings where death does not ensue. We conclude that HNE toxicity is mediated via a caspase-9-dependent pathway but that HNE accumulation need not induce cell death nor is it an obligate mediator of Abeta-induced cell death.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aldehydes / metabolism*
  • Aldehydes / toxicity
  • Amyloid beta-Peptides / metabolism*
  • Amyloid beta-Peptides / toxicity
  • Animals
  • Animals, Newborn
  • Apoptosis / drug effects
  • Apoptosis / physiology*
  • Apoptosis Regulatory Proteins
  • Apoptotic Protease-Activating Factor 1
  • Carrier Proteins / drug effects
  • Carrier Proteins / metabolism
  • Caspase 3
  • Caspase 9
  • Caspase Inhibitors
  • Caspases / metabolism
  • Central Nervous System / metabolism*
  • Central Nervous System / physiopathology
  • Dose-Response Relationship, Drug
  • Down-Regulation / drug effects
  • Down-Regulation / physiology
  • Enzyme Inhibitors / pharmacology
  • Mice
  • Mitochondrial Proteins / drug effects
  • Mitochondrial Proteins / metabolism
  • Nerve Growth Factors / deficiency
  • Neurodegenerative Diseases / metabolism*
  • Neurodegenerative Diseases / physiopathology
  • Neurons / drug effects
  • Neurons / metabolism*
  • Neurons / pathology
  • PC12 Cells
  • Proteins / metabolism
  • Rats
  • Superoxide Dismutase / deficiency
  • Superoxide Dismutase-1

Substances

  • Aldehydes
  • Amyloid beta-Peptides
  • Apaf1 protein, mouse
  • Apaf1 protein, rat
  • Apoptosis Regulatory Proteins
  • Apoptotic Protease-Activating Factor 1
  • Carrier Proteins
  • Caspase Inhibitors
  • DIABLO protein, rat
  • Diablo protein, mouse
  • Enzyme Inhibitors
  • Mitochondrial Proteins
  • Nerve Growth Factors
  • Proteins
  • Sod1 protein, mouse
  • Sod1 protein, rat
  • Superoxide Dismutase
  • Superoxide Dismutase-1
  • Casp3 protein, mouse
  • Casp3 protein, rat
  • Casp9 protein, mouse
  • Casp9 protein, rat
  • Caspase 3
  • Caspase 9
  • Caspases
  • 4-hydroxy-2-nonenal